Researchers Find Four Biomarkers Important in Colerectal Cancer Treatment Prognosis

	Tweet

Researchers at the University of Alabama at Birmingham (UAB) Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

In data presented April 19 at the American Association of Cancer Research annual meeting in Washington, D.C., Liselle Bovell, a graduate student working in the laboratory of UAB Associate Professor of Pathology Upender Manne, Ph.D., discovered that patients who tested positive for higher levels of a genetic biomarker called microRNA (miRNA) had increased risk of death after being treated for colorectal cancer.

In genetic tests of tumor samples from the patients, the presence of higher levels of miRNA-21 and miR-106a signaled poorer prognosis after treatment for both Caucasian and African-American patients compared with patients who did not have the higher miRNA levels. The presence of higher levels of miR-181b and miR-203 signaled poorer prognosis after treatment for African-American patients, but not for Caucasians.

“This knowledge gives us solid, prognostic information, so we can better manage patients with these cancers early after diagnosis or surgery,” Bovell said.

Nobel Laureate Philip A. Sharp, Ph.D., of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, hosted a press conference at the annual meeting that included Bovell and other researchers. In a statement, Sharp said, “The science of miRNAs and related small RNAs will continue to generate new insights into cancer and possible future treatment.”

The UAB researchers analyzed data from 218 patients who underwent surgery and other treatments for colorectal cancer at UAB Hospital between 1982 and 2004. They examined the gene-test results of tumor and benign-tissue samples and discovered the four miRNAs important to assessing patient survival.

For many cancers, including colon cancer, African-Americans have lower survival rates than whites. Possible reasons behind this disparity — including genetic variation, tumor characteristics, access to health care and other factors — are being examined extensively.

“Our findings underscore the potential clinical usefulness of miRNAs in studying cancer risk and cancer progression, and we’ve shown that race and ethnicity should be considered in the evaluation,” Manne said.

The research is a partnership between UAB and the Morehouse School of Medicine in Atlanta. Funding for the work comes from the National Cancer Institute.

About the UAB Department of Pathology
The UAB Department of Pathology provides extensive clinical services and instruction while maintaining large and productive research programs. Its clinical services — including inpatient, outpatient and outreach — encompass more than 6 million procedures per year. UAB’s pathology training programs are among the nation’s best, and its faculty has achieved national and international recognition in service, teaching and research.

EDITOR’S NOTE: The University of Alabama at Birmingham (UAB) is a separate, independent institution from the University of Alabama, which is located in Tuscaloosa. Please use University of Alabama at Birmingham on first reference and UAB on all consecutive references.

Source:  University of Alabama at Birmingham

RELATED STORIES:
Women on bone drugs have less colon cancer: study   People with HIV not being tested for colon cancer   Hormone therapy associated with reduced colorectal cancer risk   Dogs can accurately sniff out early stage bowel cancer   Exploring gender differences in colorectal cancer screenings   Many colon cancer patients skip follow-up care   Protein found in heart may be target for colon cancer therapies   Celecoxib May Help Prevent Colorectal Cancer In High Risk Patients   Study Finds Evidence of Gender-Related Differences In Development of Colon Cancer   Smoking-related colorectal cancer in older women is associated with molecularly-defined DNA changes   Hydrophobic proteins: Potential biomarkers for colorectal cancer   Daily drinking may raise risk of several cancers   Southern US states lag in reducing death rates from colorectal cancer   Apple pectin, apple juice extracts shown to have anticarcinogenic effects on colon   No link seen between high-carb diet, colon cancer   Aspirin vs. colon cancer: study weighs benefits   Exercise, diet may protect against colorectal cancer   Morning colonoscopy may catch more polyps   Obesity hurts recovery after colon cancer surgery   Genetic ID of Marker in Lymph Nodes May be Linked to Colorectal Cancer Recurrence Risk   Western and Japanese diets up colon cancer risk   Older Women with Diabetes Face Higher Risk for Colon Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]